Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
3
×
crispr
3
×
life sciences
3
×
national
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
crispr therapeutics
deals
detroit blog main
detroit top stories
editas medicine
eli lilly
generic drugs
indiana blog main
indiana top stories
migraine
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abalos therapeutics
What
new
3
×
bio
roundup
approval
bails
biogen’s
biopharmaceutical
brand
bridgebio
cancer
capital
car
cas
cells
companies
convo
crispr
defect
develop
drive
drug
drugs
earlier
edited
editing
emerges
failures
fears
firm
flag
gene
genetic
grab
guardian
headlines
human
ichnos
invest
known
lab
Language
unset
Current search:
new
×
cancer
×
" life sciences "
×
crispr
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells